Academia

Leverage the world’s largest, up-to-date, longitudinal clinical and claims data to generate real-world evidence.

Bring TriNetX to Your Organization

Research Institute

Utilize real-world data to excel in research. TriNetX is available for department-wide use.

Department Heads

Empower your department with data designed for scientific publications, grant submissions, poster presentations and much more.

Individual Researchers

Download data sets, perform advanced analyses for grant submissions, manuscript and poster submissions, and collaborate with like-minded researchers.

Classroom

Discover the power of data in the classroom; students and educators can iterate quickly using TriNetX, reaching real-time answers without the need for time-intensive statistical platforms.

Teachers

Communicate complex, advanced analyses to students using real data in real time. Provide students with a powerful tool to answer their clinical questions.

Students

Access data for dissertation and manuscript development. Explore EMR and claims data to learn more about target populations, compare drug effectiveness, assess real-world drug performance and much more.

Global Breadth. Unprecedented Depth. All Therapeutic Areas.

Top Therapeutic Areas

Sample Indication Counts

  • 1,003 Neuroblastoma (aged <10)
  • 2,571 Triple Negative Breast Cancer
  • 34,183 Histology Confirmed NSCLC
  • 109,412 Crohn’s Disease
  • 462,422 Pediatric Asthma

Data Characteristics

Benefits

  • Research-ready EMR data
  • All therapeutic areas
  • Comprehensive pediatric data
  • Inpatient/outpatient
  • Data curated, standardized and mapped to common data models
  • Generate replicable, generalized results
  • Detailed insight into rare diseases
  • Reduce selection bias with data sourced from diverse sites
  • Explore patient cohorts to discover comorbidities and confounders
  • Create your most accurate cohorts using temporal events, disease milestones, and in-depth medication details

Publications Using TriNetX

Alkhouli, M., Nanjundappa, A., Annie, F., et. al. (2020) Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry. Mayo Clinic Proceedings, Vol. 59 (8, 1613-1620). doi: https://doi.org/10.1016/j.mayocp.2020.05.014

Onteddu, S., Nalleballe, K., Sharma, R., et. al. (2020) Underutilization of health care for strokes during the COVID-19 outbreak. International Journal of Stroke, Vol. 15. doi: https://doi.org/10.1177%2F1747493020934362

Lamoreaux, B., Francis-Sedlak, M., Holt, R., (2020) OP0169 Amputation Procedures In Patients With Gout Compared To Patients With Diabetes. Annals of the Rheumatic Diseases. Vol. 79 (106-07). doi: http://dx.doi.org/10.1136/annrheumdis-2020-eular.2058

Hippalgaonkar, N., Matin, K., (2020) The influence of health disparities on risk factors in patients with colorectal cancer. Journal of Clinical Oncology. Vol. 38 (15). doi: 10.1200/JCO.2020.38.15_suppl.e19006

Hu, S., Shangraw, S., Newman, S. (2020). Assessing practice gaps in the outpatient management of cutaneous small vessel vasculitis. Journal of the American Academy of Dermatology. Vol. 83 (2, 657-659). doi: https://doi.org/10.1016/j.jaad.2020.01.024

Itani, N., Grogan, N., Mott, S., Phadke, S. (2020) Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival. Clinical Breast Cancer. Vol. 20 (3, 209-214). doi: https://doi.org/10.1016/j.clbc.2019.11.004

Nalleballe, K., Onteddu, S., Sharma, R., et. al. (2020). Spectrum of neuropsychiatric manifestations in COVID-19. Brain, Behavior, and Immunity. Vol. 88 (71-74). doi: https://doi.org/10.1016/j.bbi.2020.06.020

Get Started

Individual, department and institution-wide memberships are available. Contact us for more information.